Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H28O4Si4 |
| Molecular Weight | 420.7545 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[Si]1(C)O[Si@](C)(O[Si](C)(C)O[Si@](C)(O1)C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=ZTQZMPQJXABFNC-WMPKNSHKSA-N
InChI=1S/C18H28O4Si4/c1-23(2)19-25(5,17-13-9-7-10-14-17)21-24(3,4)22-26(6,20-23)18-15-11-8-12-16-18/h7-16H,1-6H3/t25-,26+
| Molecular Formula | C18H28O4Si4 |
| Molecular Weight | 420.7545 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Quadrosilan is is a synthetic nonsteroidal estrogen that was developed in the 1970s and that is or has been used as an antigonadotropic agent in the treatment of prostate cancer. It is an organosilicon compound and is also known as 2,6-cisdiphenylhexamethylcyclotetrasiloxane. Quadrosilan has estrogenic activity equivalent to that of estradiol and can produce feminization and gynecomastia as side effects in male patients.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:28:58 GMT 2025
by
admin
on
Mon Mar 31 18:28:58 GMT 2025
|
| Record UNII |
C5KT601WPM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C242
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
251-406-1
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY | |||
|
DTXSID601015701
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY | |||
|
100000081099
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY | |||
|
33204-76-1
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY | |||
|
1313268
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY | RxNorm | ||
|
C5KT601WPM
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY | |||
|
4541
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY | |||
|
C81424
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY | |||
|
20774
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY | |||
|
SUB10186MIG
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY | |||
|
C5KT601WPM
Created by
admin on Mon Mar 31 18:28:58 GMT 2025 , Edited by admin on Mon Mar 31 18:28:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
DIASTEREOISOMER -> DIASTEREOISOMER |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |